HI
TPTX

Handelsinvest Investeringsforvaltning’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-35,000
Closed -$2.33M – 120
2021
Q3 		$2.33M Hold
35,000
– – 0.25% 112
2021
Q2 		$2.73M Buy
35,000
+10,000
+40% +$739K 0.3% 105
2021
Q1 		$2.37M Hold
25,000
– – 0.29% 107
2020
Q4 		$3.05M Hold
25,000
– – 0.45% 79
2020
Q3 		$2.18M Buy
+25,000
New +$1.74M 0.41% 75

Other funds holding TPTX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's TPTX Position: Q4 2021 in Review

Handelsinvest Investeringsforvaltning sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q4 2021, closing a stake of 35,000 shares — an estimated $2.33M sold.

Handelsinvest Investeringsforvaltning first reported a position in TPTX in Q3 2020 and held it in 5 quarters. The position peaked at $3.05M in Q4 2020. 172 funds tracked by Wall St. Rank hold TPTX as of Q4 2021.

  • Handelsinvest Investeringsforvaltning reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Handelsinvest Investeringsforvaltning sold 35,000 Turning Point Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $2.33M.
  • Handelsinvest Investeringsforvaltning first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Handelsinvest Investeringsforvaltning's Turning Point Therapeutics, Inc. Common Stock position peaked at $3.05M in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2021, filed 7 Feb 2022.